Prolonged-performing Homes and likely related hazards with SUNLENCA: Residual concentrations of SUNLENCA may perhaps keep on being while in the systemic circulation of patients for as much as 12 months or more time. SUNLENCA may perhaps raise publicity, and likely danger of adverse reactions, to medicine mainly metabolized by CYP3A initiated within